Civitan International Research Center

Similar documents
Civitan International Research Center

Civitan International Research Center Achievements

ALABAMA CENTRAL EXPRESS

The Treatment of Rett Syndrome with Trofinetide (NNZ-2566): Past, Present, Future. Daniel Glaze, MD Baylor College of Medicine

Neuren s trofinetide successful in proof of concept Phase 2 clinical trial in Fragile X syndrome

PROGRAM SUBJECT TO ADDITIONS OR CHANGES *** CHECK IRSF REGISTRATION DESK FOR PROGRAM AND ROOM UPDATES ***

Neuren presents at the Rettsyndrome.org 2016 Research Symposium

restoring hope rebuilding lives

For personal use only

YOUNG MINDS MATTER: TRANSITION-AGE YOUTH. April 3, Bayou City Event Center Houston, Texas

Neurobiology and Behavior, Ph.D. in progress University of California, Irvine; Irvine, CA

2017 MEMBERSHIP PACKET

Keeping our Promises to Veterans with Disabilities

Seminars. Director: Vlad Parpura, M.D., Ph.D Coordinator: Jan Phillips

Four female faculty members in the Department of Psychology study and treat Autism Spectrum Disorder

Neurobiology and Behavior, Ph.D. in progress University of California, Irvine; Irvine, CA

FDA CLEARS NEUROSTAR TMS THERAPY FOR THE TREATMENT OF DEPRESSION

EXHIBIT & ADVERTISING INFORMATION

Glutamate. By: Sascha Ridgewell, Hannah Straughan, Hunter Scripture, Caitlyn Wibbels, & Angelina Sutton

EXHIBIT & ADVERTISING INFORMATION

In Case of Technical Difficulties

Capital Health s 6 th Annual National Neuroscience Conference (Updated 8/25/14) October 22-24, 2014 Bally s Atlantic City

Investor Update. Basel, 23 April 2018

Louisiana Chapter. Lake Charles Dementia Care Conference April 10 & 11, 2008 Trinity Baptist Church. Sponsored by:

About the Symposium. About the NAGC. Past Locations

C.V. EDUCATION EXPERIENCE TURNING POINT REHABILITATION CONSULTING, INC.

EXHIBITOR PROSPECTUS & SPONSORSHIP OPPORTUNITIES. November 8 11, 2017

Merkin Brain and Health Policy Innovation Program 2013

Sponsorship Opportunities

2015 ASNM Fall Symposium

THE CANADA-ISRAEL TRANS-ATLANTIC COLLABORATION FOR BRAIN STUDIES

Bryan S. Lovelace M.S. BCBA 1619 Dream Catcher Way Krum, TX

Investor Presentation. 2 June 2017

Don t lose your life to NPH.

Patients at high-risk for lung cancer are more likely to receive screening when primary care provider is familiar with guideline recommendations

FRIENDS MIND. High quality MRIs without sedation now possible for children with autism spectrum disorder

AOPT. 13 Scientific Meeting OCULAR THERAPEUTICS: VISION OF HOPE IN A CHANGING WORLD. February 16th-19th, Florence (Italy)

AMERICAN INSTITUTE OF ARCHITECTS ILLINOIS - INVESTMENT OPPORTUNITIES

NEUROLOGY FOR PRIMARY CARE. San Diego, California Hotel del Coronado August 9 12, 2018

Academy of Pediatric Physical Therapy

Membership Leadership Program of Civitan International

Investor Presentation. 3 April 2017

Investor Update. Downloads. Services PDF. Basel, 17 July 2017

Sponsor & Vendor Packet

Disclaimer. Dialogue with a Patient 3/18/2016

Shawanda M. Benjamin. February 24, 2017

2016 Programs & Information

groundbreaking partnership to help many thousands of Australians, and their families, whose lives are scarred by bipolar disorder

BioArctic announces detailed results of the BAN2401 Phase 2b study in early Alzheimer s disease presented at AAIC 2018

12 TH ANNUAL NEUROPATHY ACTION AWARENESS DAY JUNE 22, 2018 INTERCONTINENTAL LOS ANGELES LIVE VIDEO STREAMING AVAILABLE

Fred Taubman Director of Marketing Development and Communications, HDSA

Life Time Corporate Membership Subsidy Program. Committed to your company s health.

Inpatient Acute Rehabilitation

Gofal Annual. Report Celebrating 25 years of supporting people with mental health problems in Wales

PERSONAL INFORMATION. Address: Alta Vista Cir. Huntington Beach, Ca VALID & CURRENT: EDUCATOIN

Jessica F. Baird, PhD 513 Oaks Dr, Birmingham, AL Phone: (716)

2nd Annual Neurosciences Update Conference

Spinal Cord Injury Fact Sheet

DALLAS ASSOCIATION OF HEALTH UNDERWRITERS NEWSLETTER

CURRICULUM VITAE. Vestibular Certificate of Competency, Course Director: Susan Herdmam, PT, PhD, FAPTA, March 2002

SHS State of the Society

KIMBERLY A KLEIN, PH.D., L.P. Curriculum Vitae

MORNING COFFEE

SEVENTH INTERNATIONAL WORKSHOP ON DOSIMETRY FOR RADIATION PROCESSING

MARY NORD COOK, MD. Naval Medical Center, San Diego, California General Psychiatry Residency, July 1994-July 1997

MEDICAL RESEARCH WITH VALLEY STROKE PATIENTS PRESENTED AT INTERNATIONAL CONFERENCE IN PHILADELPHIA

2019 PARTNER PROSPECTUS

DALLAS ASSOCIATION OF HEALTH UNDERWRITERS NEWSLETTER

Commitment. to Cure. Every year, one in five Australians is struck down with a major brain or mind disorder.

Association for Positive Behavior Support

Home Builders Foundation of Metro Denver 2015 Annual Sponsorship Packages

Exploring the Spectrum Conference

Neuropsychology Of Childhood Epilepsy (Advances In Behavioral Biology)

JOBTOBERFEST Balboa Park Club Inn 2144 Pan American Rd. W. San Diego, CA

Children s Research Institute

DIOXIN SYMPOSIUM MEETING PLANNING

Oral Health Florida General Membership Wednesday, April 23, :00pm-1:00pm EDT

DUBAI, April 02-04,2018. Theme : Meeting the challenges to eliminate barriers to oral and Dental care.

Advance Health Solutions, LLC!

December 2, Taube Foundation Huntington s Disease Symposium. Course Chair Stanley B. Prusiner, MD Course Fee $25

6/20/2012. Early Stage. Part 1. Learning objectives: Early-Stage Program. Understanding dementia. Understanding Alzheimer s disease

Curriculum Vitae. Graves T Owen, MD Birth Date: 01/15/1962 Birth Place: Austin, Texas Round Rock, Texas 78681

2. G20 World Brain Mapping Summit at Uskudar University

AAA. Report #14 Transitioning Together: Developing an Education and Support Program for Families. - Principal Investigators -

Statewide Services for Traumatic Brain Injuries, Alzheimer s Disease, and Dementia

S P E C I A L I Z E D M E D I C A L C E N T E R F OR N E U R OLO G Y

ADC Directors Meeting

Hope. Giving. October - December Latidos de Esperanza Quarterly Newsletter. Letter from the Executive Director

Board Meeting Thursday, July 24, :45 AM - 11:30 AM Vestavia Hills Chamber of Commerce Board Room

Galderma Pre-Board Slide Seminar 2009 July 17-19, 2009

WV PICCS TODAY. Note of Appreciation. A newsletter for our partners. In This Issue. December 2016

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, postpolio syndrome, rheumatoid arthritis, lupus

Frederick James de la Vega, M.D.

Neurology & Brain Disorders

Helping Patients and Families Understand Fragile X Syndrome

Samantha K. Holden, MD East 17th Avenue Campus Box B185 Aurora, CO Phone:

YOU ARE THE WAVE CENTERPOINT ENERGY POWERTOOLS FOR NONPROFITS WELCOME REMARKS BY SHARON M. OWENS VICE PRESIDENT COMMUNITY RELATIONS

NEW FOR YOU! The Mercian Collaboration Conference TH SEPTEMBER #Mercian18 New for You

DIVISION OF INDEPENDENT PROFESSIONAL PRACTICE 2016 PRACTICE CONFERENCE

Transcription:

Civitan International Research Center January 2017 UPCOMING EVENTS B ham Sci Café January 17, 2017 Governor Elect s Tour January 23, 2017 Past-Governors February 4, 2017 CIRC Symposium April 20, 2017 Centennial Celebration June 24 27, 2017 I N S I D E Happy New Year 1 Research Spotlight 2 Upcoming Events 3 Tours 4 DIRECTORS Alan Percy, MD Interim Director Lucas Pozzo-Miller, PhD Scientific Co-director Rita Cowell, PhD Director Communications and Outreach Vicki Hixon, BS Managing Director HAPPY NEW YEAR from the Civitan International Research Center!!! As we reflect on the successes of years past, we anticipate 2017 with excitement about the future of The Civitan International Research Center (CIRC). We want to thank you for your support and dedication over the years. Without your commitment and diligent work, we would not be where we are today. We are excited about the research currently being done at the CIRC. Research continues at a rapid pace with the help of the new state-of-the-art full-body magnetic resonance imaging scanner. The imaging equipment is being used for both research purposes and patient care in conditions such as autism, dementia, Alzheimer s disease, Parkinson s disease, schizophrenia, macular degeneration, spinal cord injury, glioma, ALS and traumatic brain injury.

Global Study on Rett Syndrome UAB part of global study of breathing issues in Rett syndrome by Bob Shepard - December 16, 2016 UAB will study a drug originally developed for Parkinson s disease that may help reduce breath holding in patients with Rett syndrome. Researchers at the University of Alabama at Birmingham are part of the international STARS study to see if a drug originally developed for Parkinson s disease might help reduce breathing issues common in patients with Rett syndrome. The drug, sarizotan, may help reduce the frequency of breath holding, a potentially significant effect of Rett syndrome. We often see Rett patients holding their breath for long periods of time, up to 30 seconds at a time, behavior that can go on for hours, said Alan Percy, M.D., professor of neurology in the Department of Pediatrics, medical director of the UAB Civitan International Research Center and a leading Rett syndrome expert. Patients often end up swallowing large amounts of air, which can have a very detrimental effect on nutrition, a major issue for Rett patients. The study, to be held in four sites in the United States and several international locations, is looking to enroll patients with Rett syndrome who are 13 years and older, have a body weight of at least 55 pounds and experience multiple episodes of breath holding while awake during the day. Breath holding can be quite disruptive in younger Rett patients, although it usually subsides in early adulthood, Percy said. We currently do not have an effective medication that addresses breath holding. This is the first multisite trial of a potential therapy. While this is certainly not curative for Rett syndrome, it could be disease modifying, Percy said. This has the potential to be an important drug, as breath holding can be very disruptive and distressing to the family. The National Institutes of Health defines Rett syndrome as a neurodevelopmental disorder that affects girls almost exclusively. It is characterized by normal early growth and development followed by a slowing of development, loss of purposeful use of the hands, distinctive hand movements, slowed brain and head growth, problems with walking, seizures, and intellectual disability. The study is sponsored by Newron Pharmaceuticals U.S., Inc. Other study sites in the United States are the Altman Clinical and Translation Research Institute, University of California San Diego; Rush Medical University Center, Chicago; and Texas Children s Hospital, Houston. Page 2

Upcoming Events SAVE-THE-DATE Thursday, April 20, 2017 Civitan International Simpson Ramsey Neurodevelopment Symposium Hill Center 8:30 a.m. 3:00 p.m. Poster Session The Edge of Chaos 3:30 p.m. 5:30 p.m. The event will feature keynote speakers along with UAB researchers who will share knowledge about their on-going research. Page 3

Celebrating 100 Years! Civitan International Centennial Celebration Birmingham, Alabama June 24 27, 2017 Excitement is growing in anticipation of the Centennial Celebration to be held at the beautiful Sheraton Birmingham Downtown Hotel. For more information visit: http://www.civitan.org/convention2017/conventioninformation2017.pdf Page 4

Civitan International Research Center Page 5